Author

J. Botton

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Use of Sotatercept in France since Its Availability in June 2024: A Nationwide Study from the French Health Data System (SNDS).

BACKGROUND Pulmonary arterial hypertension (PAH) is a rare, severe and progressive disease associated with poor quality of life and high mortality. Sotatercept, a first-in-class fusion protein, has recently been shown to provide substantial clinical benefit as add-on therapy in PAH and was made available in France in 2...

Nazoiri Charifa, Alain Weill, M. Zureik et al. · Drugs - Real World Outcomes · 0 citations

Open access Oct 2026

Absolute and Relative Effectiveness of High-Dose vs Standard-Dose Influenza Vaccines Against Severe Outcomes in Older Adults

Importance Several influenza vaccine products are available for older adults, but evidence combining both their absolute effectiveness and head-to-head comparisons within the same large population remains scarce, limiting product-specific vaccination guidance for this high-risk group. Objective To estimate the relative...

S. Le Vu, N. Gutierrez-Melo, T. Cartailler et al. · medRxiv · 0 citations

Open access Oct 2026

Estimation of the relative effectiveness and waning of the monovalent third dose of COVID-19 vaccine against hospital admission in France: a novel self-controlled case series analysis.

We present a novel application of the SCCS method for estimating the effectiveness and waning of the third dose of COVID-19 monovalent vaccine in France. We used data on individuals hospitalised for COVID-19 between September 2021 and February 2022 from the Système National des Données de Santé. Only cases having recei...

J. Botton, Yonas Ghebremichael-Weldeselassie, M. Hocine et al. · American Journal of Epidemio... · 0 citations